Suppr超能文献

由SARS-CoV-2疫苗引发的结节性痒疹爆发

Prurigo Nodularis Eruption Triggered by SARS-CoV-2 Vaccine.

作者信息

Barnawi Ghassan, Alghamdi Fareeda S, Almuqati Amer S, Alamri Awadh

机构信息

Dermatology, King Abdulaziz Medical City, Jeddah, SAU.

Plastic and Reconstructive Surgery, King Abdulaziz Medical City, Jeddah, SAU.

出版信息

Cureus. 2022 Oct 4;14(10):e29914. doi: 10.7759/cureus.29914. eCollection 2022 Oct.

Abstract

We discuss a case of a 63-year-old male who presented with generalized itchy papulonodular rash a few weeks after receiving a vaccination against SARS-CoV-2. The patient had a negative medical history for atopic dermatitis and other pruritic skin conditions, and clinical presentation was consistent with prurigo nodularis, which was confirmed later by tissue biopsy and microscopic analysis. The pathophysiology of this skin condition is thought to be due to an overlap between the immune and nervous systems. Due to the hypothesized involvement of the immune system in this disease, it. is presumed that the patient had a dysregulated immune response caused by his recent SARS-CoV-2 vaccination.

摘要

我们讨论一例63岁男性病例,该患者在接种抗SARS-CoV-2疫苗几周后出现全身性瘙痒性丘疹结节性皮疹。患者既往无特应性皮炎和其他瘙痒性皮肤病病史,临床表现符合结节性痒疹,后来经组织活检和显微镜分析得以证实。这种皮肤疾病的病理生理学被认为是由于免疫系统和神经系统之间的重叠。由于推测免疫系统参与了这种疾病,据推测患者最近接种SARS-CoV-2疫苗导致了免疫反应失调。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c209/9633006/a9996e3ccb2a/cureus-0014-00000029914-i01.jpg

相似文献

1
Prurigo Nodularis Eruption Triggered by SARS-CoV-2 Vaccine.
Cureus. 2022 Oct 4;14(10):e29914. doi: 10.7759/cureus.29914. eCollection 2022 Oct.
2
Prurigo nodularis in a 9-year-old girl.
Clin Pediatr (Phila). 2009 Jan;48(1):93-5. doi: 10.1177/0009922808321899. Epub 2008 Jul 22.
3
Dupilumab Treatment for Prurigo Nodularis and Pruritis.
J Drugs Dermatol. 2019 Sep 1;18(9):940-942.
4
Chronic Prurigo: An Unusual Presentation of Hodgkin Lymphoma.
Case Rep Dermatol. 2018 May 17;10(2):122-126. doi: 10.1159/000489161. eCollection 2018 May-Aug.
5
A Fleshy Mystery: Prurigo Nodularis.
Cureus. 2024 Jul 22;16(7):e65125. doi: 10.7759/cureus.65125. eCollection 2024 Jul.
6
A Case of Linear Exacerbation of Atopic Dermatitis with Secondary Prurigo Nodularis.
Ann Dermatol. 2022 Aug;34(4):297-300. doi: 10.5021/ad.20.072.
7
Acral Prurigo Nodularis: A Case Report.
Cureus. 2022 Sep 21;14(9):e29405. doi: 10.7759/cureus.29405. eCollection 2022 Sep.
8
Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response.
J Dermatolog Treat. 2022 May;33(3):1547-1553. doi: 10.1080/09546634.2020.1853024. Epub 2020 Dec 3.
9
Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis.
Actas Dermosifiliogr. 2022 Jul-Aug;113(7):674-684. doi: 10.1016/j.ad.2021.12.014. Epub 2021 Dec 23.

本文引用的文献

1
Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccines.
J Eur Acad Dermatol Venereol. 2021 Dec;35(12):2456-2461. doi: 10.1111/jdv.17633. Epub 2021 Sep 16.
2
Prurigo Nodularis: Review and Emerging Treatments.
Skin Therapy Lett. 2021 May;26(3):5-8.
3
Dupilumab Treatment for Prurigo Nodularis and Pruritis.
J Drugs Dermatol. 2019 Sep 1;18(9):940-942.
4
Pruritus: Progress toward Pathogenesis and Treatment.
Biomed Res Int. 2018 Apr 11;2018:9625936. doi: 10.1155/2018/9625936. eCollection 2018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验